Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  DOT1L inhibitor EPZ-5676
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EPZ-5676-12-001, NCI-2012-02880, NCT01684150
Dose Escalation Study of EPZ-5676 in Pediatric Patients With Leukemias Bearing a Rearrangement of the MLL Gene
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 months to 17 years
Trial IDs: EPZ-5676-12-002, NCI-2014-01972, NCT02141828
Start Over